+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ICO Therapeutics Inc - logo

iCo Therapeutics is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. Its business model aims to acquire the rights to drugs that are either off-patent, currently approved or near commercialization and develop them. The company's product candidates include iCo-007, iCo-008 and an Oral Amphotericin B (Amp B) Delivery System.

Bullous Pemphigoid - Pipeline Review, H1 2020 - Product Thumbnail Image

Bullous Pemphigoid - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 139 pages
From
Candidiasis - Pipeline Insight, 2020 - Product Thumbnail Image

Candidiasis - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 pages
From
Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2020 - Product Thumbnail Image

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 146 pages
From
Aspergillosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Aspergillosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 196 pages
From
Candidiasis R&D Pipeline Analysis Report, Q4 2020 - Product Thumbnail Image

Candidiasis R&D Pipeline Analysis Report, Q4 2020

  • Report
  • October 2020
  • 210 pages
From
Candidiasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Candidiasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 225 pages
From
Leishmaniasis - Pipeline Insight, 2020 - Product Thumbnail Image

Leishmaniasis - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 pages
From
Aspergillosis R&D Pipeline Analysis Report, Q4 2020 - Product Thumbnail Image

Aspergillosis R&D Pipeline Analysis Report, Q4 2020

  • Report
  • October 2020
  • 135 pages
From
From
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017

  • Drug Pipelines
  • February 2017
  • 402 pages
From
From
From
From
Aspergillosis R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Aspergillosis R&D Pipeline Analysis Report, H2-2018

  • Report
  • August 2018
  • 100 pages
From
Candidiasis R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Candidiasis R&D Pipeline Analysis Report, H2-2018

  • Report
  • August 2018
  • 140 pages
From
Loading Indicator
adroll